Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 2Plasma cell 2Other hematologic neoplasm 1Lymphoid 1Gastrointestinal 1CNS 1

Conditions

Pancreatic Neoplasms 1Lipodystrophy, Congenital Generalized 1

Interventions

Fluorouracil 145Gemcitabine 141Oxaliplatin 135Capecitabine 133Leucovorin 107Irinotecan 99Bevacizumab 92Cetuximab 69Cisplatin 67pembrolizumab 61Radiotherapy 60Nivolumab 41130-nm albumin-bound paclitaxel 41Sorafenib 39Docetaxel 34Albumin-Bound Paclitaxel 31Radiosurgery 28Paclitaxel 27Surgical Procedures, Operative 25regorafenib 24Erlotinib Hydrochloride 23Panitumumab 22Cyclophosphamide 21Celecoxib 20Trastuzumab 19Radiation 18Neoadjuvant Therapy 18IFL protocol 18atezolizumab 17Carboplatin 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Tetanus Toxoid × Gastrointestinal × Clear all
NCT03848182 2024-04-18

Analyzing Childhood Recall Antigens in Patients With Pancreatic Cancer

Albert Einstein College of Medicine

Phase 2 Terminated
10 enrolled 7 charts
Gastrointestinal

Pancreatic Neoplasms, Lipodystrophy, Congenital Generalized

Data powered by HemOnc (CC BY 4.0) Colophon âš¡